Last updated on March 2019

Study of Sulfatinib as Second-line Treatment in Patients With Biliary Tract Carcinoma


Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.